PFS @ 6 months - Open label
Looks like we have a new significant holder. Bolder now owns 1% of Thallion.
This is an open label trial. Thallion already knows the success rate. They are waiting for the last patient to cross the finishing line at 6 months.
Management has been acting on success scenario all along. Tax loss conversion, apoptosis poster, conference call detailling no side effect.
We move closer and closer to D-Day,
Liquidation value puts this stock north of 0,30$.
Win win scenario.